Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer
To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performa...
Gespeichert in:
Veröffentlicht in: | Clinical radiology 2019-10, Vol.74 (10), p.818.e17-818.e23 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 818.e23 |
---|---|
container_issue | 10 |
container_start_page | 818.e17 |
container_title | Clinical radiology |
container_volume | 74 |
creator | Yang, D.D. Mirvis, E. Goldring, J. Patel, A.R.C. Wagner, T. |
description | To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performance of PET/CT in non-small cell lung cancer (NSCLC).
All patients diagnosed with NSCLC who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and 18F-FDG-PET/CT between June 2016 and August 2018 were included. Nodal station and nodal staging-based analyses were performed, comparing the MBP cut-off and five other PET/CT parameters (node maximum standardised uptake value [SUVmax], node/MBP SUVmax ratio, node/tumour SUVmax ratio, node short axis diameter, and node SUVmax/node short axis diameter ratio) with histopathology results. The optimal cut-off value for each PET/CT parameter was determined using receiver operating characteristic curve analysis.
One hundred and thirteen patients with a total of 321 nodes with pathological sampling were included. Nodal activity above MBP on PET/CT demonstrated 97.4% sensitivity, 35.8% specificity, 32.8% positive predictive value, and 97.8% negative predictive value. Of the five other PET/CT parameters examined, the two most promising were node SUVmax and node/MBP SUVmax. The node SUVmax cut-off of 3.9 demonstrated 90.9% sensitivity and 61.9% specificity, and the node/MBP SUVmax cut-off of 1.7 demonstrated 90.9% sensitivity and 60.7% specificity.
Compared to the MBP cut-off, use of a higher node/MBP SUVmax ratio cut-off and use of other PET/CT variables can improve the diagnostic performance of PET/CT for NSCLC nodal staging. In particular, specificity for detecting malignant nodal involvement is improved while maintaining high sensitivity.
•Using different PET/CT cut-offs can improve diagnostic performance in NSCLC staging.•SUVmax cut-off 3.9 demonstrated sensitivity 90.9% and specificity 61.9%.•Node/MBP SUVmax cut-off 1.7 demonstrated sensitivity 90.9% and specificity 60.7%. |
doi_str_mv | 10.1016/j.crad.2019.07.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2275272741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926019303538</els_id><sourcerecordid>2275272741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2441-6d82582f94bac8be2968d604c20ebdb464f828b11909b0f3097a87baf1e33e483</originalsourceid><addsrcrecordid>eNp9ULFOwzAQtRBIlMIPMGVkSWo7bmJLLKi0pVIlGIrEZjnOpXKV2MVOIzHw7ziUmeVOd_fe3b2H0D3BGcGkmB0y7VWdUUxEhssMY3GBJiQv5iml4uMSTXBspYIW-BrdhHAYS0bZBH1vuqN3g7H7pDZqb13ojU6O4BvnO2U1JK5JCF-lq-d1-rbczRa7JI4SFQKE0IHtR4CHvXFWtYl1dYzGDq4d4HdqbGzaNHSqbRMNMbSneEyPu_0tumpUG-DuL0_R-2q5W7yk29f1ZvG0TTVljKRFzemc00awSmleARUFrwvMNMVQ1RUrWMMprwgRWFS4ybEoFS8r1RDIc2A8n6KH896o9fMEoZedCeMzyoI7BUlpOaclLRmJUHqGau9C8NDIozed8l-SYDl6LQ9y9FqOXktcyuhkJD2eSRBFDAa8DNpAVFgbD7qXtTP_0X8A3QSISg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2275272741</pqid></control><display><type>article</type><title>Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Yang, D.D. ; Mirvis, E. ; Goldring, J. ; Patel, A.R.C. ; Wagner, T.</creator><creatorcontrib>Yang, D.D. ; Mirvis, E. ; Goldring, J. ; Patel, A.R.C. ; Wagner, T.</creatorcontrib><description>To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performance of PET/CT in non-small cell lung cancer (NSCLC).
All patients diagnosed with NSCLC who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and 18F-FDG-PET/CT between June 2016 and August 2018 were included. Nodal station and nodal staging-based analyses were performed, comparing the MBP cut-off and five other PET/CT parameters (node maximum standardised uptake value [SUVmax], node/MBP SUVmax ratio, node/tumour SUVmax ratio, node short axis diameter, and node SUVmax/node short axis diameter ratio) with histopathology results. The optimal cut-off value for each PET/CT parameter was determined using receiver operating characteristic curve analysis.
One hundred and thirteen patients with a total of 321 nodes with pathological sampling were included. Nodal activity above MBP on PET/CT demonstrated 97.4% sensitivity, 35.8% specificity, 32.8% positive predictive value, and 97.8% negative predictive value. Of the five other PET/CT parameters examined, the two most promising were node SUVmax and node/MBP SUVmax. The node SUVmax cut-off of 3.9 demonstrated 90.9% sensitivity and 61.9% specificity, and the node/MBP SUVmax cut-off of 1.7 demonstrated 90.9% sensitivity and 60.7% specificity.
Compared to the MBP cut-off, use of a higher node/MBP SUVmax ratio cut-off and use of other PET/CT variables can improve the diagnostic performance of PET/CT for NSCLC nodal staging. In particular, specificity for detecting malignant nodal involvement is improved while maintaining high sensitivity.
•Using different PET/CT cut-offs can improve diagnostic performance in NSCLC staging.•SUVmax cut-off 3.9 demonstrated sensitivity 90.9% and specificity 61.9%.•Node/MBP SUVmax cut-off 1.7 demonstrated sensitivity 90.9% and specificity 60.7%.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2019.07.009</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Clinical radiology, 2019-10, Vol.74 (10), p.818.e17-818.e23</ispartof><rights>2019 The Royal College of Radiologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2441-6d82582f94bac8be2968d604c20ebdb464f828b11909b0f3097a87baf1e33e483</citedby><cites>FETCH-LOGICAL-c2441-6d82582f94bac8be2968d604c20ebdb464f828b11909b0f3097a87baf1e33e483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2019.07.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Yang, D.D.</creatorcontrib><creatorcontrib>Mirvis, E.</creatorcontrib><creatorcontrib>Goldring, J.</creatorcontrib><creatorcontrib>Patel, A.R.C.</creatorcontrib><creatorcontrib>Wagner, T.</creatorcontrib><title>Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer</title><title>Clinical radiology</title><description>To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performance of PET/CT in non-small cell lung cancer (NSCLC).
All patients diagnosed with NSCLC who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and 18F-FDG-PET/CT between June 2016 and August 2018 were included. Nodal station and nodal staging-based analyses were performed, comparing the MBP cut-off and five other PET/CT parameters (node maximum standardised uptake value [SUVmax], node/MBP SUVmax ratio, node/tumour SUVmax ratio, node short axis diameter, and node SUVmax/node short axis diameter ratio) with histopathology results. The optimal cut-off value for each PET/CT parameter was determined using receiver operating characteristic curve analysis.
One hundred and thirteen patients with a total of 321 nodes with pathological sampling were included. Nodal activity above MBP on PET/CT demonstrated 97.4% sensitivity, 35.8% specificity, 32.8% positive predictive value, and 97.8% negative predictive value. Of the five other PET/CT parameters examined, the two most promising were node SUVmax and node/MBP SUVmax. The node SUVmax cut-off of 3.9 demonstrated 90.9% sensitivity and 61.9% specificity, and the node/MBP SUVmax cut-off of 1.7 demonstrated 90.9% sensitivity and 60.7% specificity.
Compared to the MBP cut-off, use of a higher node/MBP SUVmax ratio cut-off and use of other PET/CT variables can improve the diagnostic performance of PET/CT for NSCLC nodal staging. In particular, specificity for detecting malignant nodal involvement is improved while maintaining high sensitivity.
•Using different PET/CT cut-offs can improve diagnostic performance in NSCLC staging.•SUVmax cut-off 3.9 demonstrated sensitivity 90.9% and specificity 61.9%.•Node/MBP SUVmax cut-off 1.7 demonstrated sensitivity 90.9% and specificity 60.7%.</description><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9ULFOwzAQtRBIlMIPMGVkSWo7bmJLLKi0pVIlGIrEZjnOpXKV2MVOIzHw7ziUmeVOd_fe3b2H0D3BGcGkmB0y7VWdUUxEhssMY3GBJiQv5iml4uMSTXBspYIW-BrdhHAYS0bZBH1vuqN3g7H7pDZqb13ojU6O4BvnO2U1JK5JCF-lq-d1-rbczRa7JI4SFQKE0IHtR4CHvXFWtYl1dYzGDq4d4HdqbGzaNHSqbRMNMbSneEyPu_0tumpUG-DuL0_R-2q5W7yk29f1ZvG0TTVljKRFzemc00awSmleARUFrwvMNMVQ1RUrWMMprwgRWFS4ybEoFS8r1RDIc2A8n6KH896o9fMEoZedCeMzyoI7BUlpOaclLRmJUHqGau9C8NDIozed8l-SYDl6LQ9y9FqOXktcyuhkJD2eSRBFDAa8DNpAVFgbD7qXtTP_0X8A3QSISg</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Yang, D.D.</creator><creator>Mirvis, E.</creator><creator>Goldring, J.</creator><creator>Patel, A.R.C.</creator><creator>Wagner, T.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201910</creationdate><title>Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer</title><author>Yang, D.D. ; Mirvis, E. ; Goldring, J. ; Patel, A.R.C. ; Wagner, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2441-6d82582f94bac8be2968d604c20ebdb464f828b11909b0f3097a87baf1e33e483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, D.D.</creatorcontrib><creatorcontrib>Mirvis, E.</creatorcontrib><creatorcontrib>Goldring, J.</creatorcontrib><creatorcontrib>Patel, A.R.C.</creatorcontrib><creatorcontrib>Wagner, T.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, D.D.</au><au>Mirvis, E.</au><au>Goldring, J.</au><au>Patel, A.R.C.</au><au>Wagner, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer</atitle><jtitle>Clinical radiology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>74</volume><issue>10</issue><spage>818.e17</spage><epage>818.e23</epage><pages>818.e17-818.e23</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><abstract>To assess the diagnostic performance of combined 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) mediastinal blood pool (MBP) activity cut-off for staging nodal involvement, and to examine other variables that may improve the diagnostic performance of PET/CT in non-small cell lung cancer (NSCLC).
All patients diagnosed with NSCLC who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and 18F-FDG-PET/CT between June 2016 and August 2018 were included. Nodal station and nodal staging-based analyses were performed, comparing the MBP cut-off and five other PET/CT parameters (node maximum standardised uptake value [SUVmax], node/MBP SUVmax ratio, node/tumour SUVmax ratio, node short axis diameter, and node SUVmax/node short axis diameter ratio) with histopathology results. The optimal cut-off value for each PET/CT parameter was determined using receiver operating characteristic curve analysis.
One hundred and thirteen patients with a total of 321 nodes with pathological sampling were included. Nodal activity above MBP on PET/CT demonstrated 97.4% sensitivity, 35.8% specificity, 32.8% positive predictive value, and 97.8% negative predictive value. Of the five other PET/CT parameters examined, the two most promising were node SUVmax and node/MBP SUVmax. The node SUVmax cut-off of 3.9 demonstrated 90.9% sensitivity and 61.9% specificity, and the node/MBP SUVmax cut-off of 1.7 demonstrated 90.9% sensitivity and 60.7% specificity.
Compared to the MBP cut-off, use of a higher node/MBP SUVmax ratio cut-off and use of other PET/CT variables can improve the diagnostic performance of PET/CT for NSCLC nodal staging. In particular, specificity for detecting malignant nodal involvement is improved while maintaining high sensitivity.
•Using different PET/CT cut-offs can improve diagnostic performance in NSCLC staging.•SUVmax cut-off 3.9 demonstrated sensitivity 90.9% and specificity 61.9%.•Node/MBP SUVmax cut-off 1.7 demonstrated sensitivity 90.9% and specificity 60.7%.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.crad.2019.07.009</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9260 |
ispartof | Clinical radiology, 2019-10, Vol.74 (10), p.818.e17-818.e23 |
issn | 0009-9260 1365-229X |
language | eng |
recordid | cdi_proquest_miscellaneous_2275272741 |
source | ScienceDirect Journals (5 years ago - present) |
title | Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A24%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improving%20diagnostic%20performance%20of%2018F-FDG-PET/CT%20for%20assessment%20of%20regional%20nodal%20involvement%20in%20non-small%20cell%20lung%20cancer&rft.jtitle=Clinical%20radiology&rft.au=Yang,%20D.D.&rft.date=2019-10&rft.volume=74&rft.issue=10&rft.spage=818.e17&rft.epage=818.e23&rft.pages=818.e17-818.e23&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2019.07.009&rft_dat=%3Cproquest_cross%3E2275272741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2275272741&rft_id=info:pmid/&rft_els_id=S0009926019303538&rfr_iscdi=true |